Abstract
Designing reactive calcium-based nanogenerators to produce excess calcium ions (Ca2+) in tumor cells is an attractive tumor treatment method. However, nanogenerators that introduce exogenous Ca2+ are either overactive incapable of on-demand release, or excessively inert incapable of an overload of calcium rapidly. Herein, inspired by inherently diverse Ca2+-regulating channels, a photo-controlled Ca2+ nanomodulator that fully utilizes endogenous Ca2+ from dual sources was designed to achieve Ca2+ overload in tumor cells. Specifically, mesoporous silica nanoparticles were used to co-load bifunctional indocyanine green as a photodynamic/photothermal agent and a thermal-sensitive nitric oxide (NO) donor (BNN-6). Thereafter, they were coated with hyaluronic acid, which served as a tumor cell-targeting unit and a gatekeeper. Under near-infrared light irradiation, the Ca2+ nanomodulator can generate reactive oxygen species that stimulate the transient receptor potential ankyrin subtype 1 channel to realize Ca2+ influx from extracellular environments. Simultaneously, the converted heat can induce BNN-6 decomposition to generate NO, which would open the ryanodine receptor channel in the endoplasmic reticulum and allow stored Ca2+ to leak. Both in vitro and in vivo experiments demonstrated that the combination of photo-controlled Ca2+ influx and release could enable Ca2+ overload in the cytoplasm and efficiently inhibit tumor growth.
| Original language | English |
|---|---|
| Article number | e202317578 |
| Journal | Angewandte Chemie - International Edition |
| Volume | 63 |
| Issue number | 9 |
| DOIs | |
| State | Published - 26 Feb 2024 |
Bibliographical note
Publisher Copyright:© 2024 Wiley-VCH GmbH.
Keywords
- Calcium Ion Overload
- Mesoporous Silica Nanoparticles
- Nitric Oxide
- TRPA1 Channel
- Tumor Therapy
Fingerprint
Dive into the research topics of 'Photo-Controlled Calcium Overload from Endogenous Sources for Tumor Therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver